Breaking

Trump China tariff truce ignites stock markets – will it also pump up president’s poll numbers?
House GOP unveils Medicaid work requirements in Trump’s ‘big, beautiful bill’
Europe and US briefly upped the pressure on Russia over Ukraine. Trump upended that
4th round of US-Iran talks ends as Trump set to embark on historic Middle East tour
Missiles, drones and airstrikes, until a sudden ceasefire. How India and Pakistan agreed to an uneasy truce
In China, some see the ghost of Mao as Trump upends America and the world
Pope! Amigo! Peruvians remember the young American priest who became pope
Dozens of boxes of Nazi materials found in basement at top Argentinian court

Politics
Business
World
Investing
Search for:

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Multiple New Multi-Commodity Targets

Acceleration of RAD204 Phase 1 dose escalation trial

Excellent Gold Intersections Verified at Kiimala Project

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,639)
- Investing (4,788)
- Politics (7,522)
- Uncategorized (6)
- World (6,117)

Disclaimer: safefuturetomorrow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 safefuturetomorrow.com | All Rights Reserved

Top

Politics
Business
World
Investing

Type above and press Enter to search. Press Esc to cancel.